10874 | -0.466 | 10.16 | -6.941 | 0.000229 | 3.412 | NMU | neuromedin U | ENSG00000109255 | 605103 | 10874 | A_23_P69537 |
11116 | -0.603 | 8.639 | -8.521 | 4.87e-05 | 5.638 | FGFR1OP | FGFR1 oncogene partner | ENSG00000213066 | 605392 | 11116 | A_23_P145134 |
2247 | 0.881 | 8.143 | 7.841 | 9.21e-05 | 4.72 | FGF2 | fibroblast growth factor 2 (basic) | ENSG00000138685 | 134920 | 2247 | A_23_P218918 |
22916 | 0.4906 | 10.15 | 6.825 | 0.000262 | 3.237 | NCBP2 | nuclear cap binding protein subunit 2, 20kDa | ENSG00000114503 | 605133 | 22916 | A_23_P155316 |
285381 | 0.717 | 9.903 | 8.682 | 4.33e-05 | 5.846 | DPH3 | DPH3, KTI11 homolog (S. cerevisiae) | ENSG00000154813 | 608959 | 285381 | A_23_P69188 |
301 | 0.3843 | 12.13 | 7.007 | 0.0002147 | 3.512 | ANXA1 | annexin A1 | ENSG00000135046 | 151690 | 301 | A_23_P94501 |
302 | 1.004 | 13.44 | 9.447 | 2.34e-05 | 6.8 | ANXA2 | annexin A2 | ENSG00000182718 | 151740 | 302 | A_23_P146644 |
3084 | 0.4635 | 6.738 | 8.039 | 7.66e-05 | 4.993 | NRG1 | neuregulin 1 | ENSG00000157168 | 142445, 603013 | 3084 | A_23_P136493 |
3383 | 0.8144 | 8.251 | 13 | 2.46e-06 | 10.5 | ICAM1 | intercellular adhesion molecule 1 | ENSG00000090339 | 147840, 248310, 611162 | 3383 | A_23_P153320 |
3486 | 1.074 | 7.405 | 7.202 | 0.0001752 | 3.803 | IGFBP3 | insulin-like growth factor binding protein 3 | ENSG00000146674 | 146732 | 3486 | A_23_P215634 |
3516 | 0.5271 | 8.589 | 8.523 | 4.87e-05 | 5.641 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | ENSG00000168214 | 147183 | 3516 | A_23_P113244 |
3572 | 0.4047 | 7.072 | 6.747 | 0.0002855 | 3.117 | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | ENSG00000134352 | 600694 | 3572 | A_23_P502470 |
3673 | 0.8997 | 7.33 | 7.721 | 0.0001034 | 4.551 | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | ENSG00000164171 | 192974 | 3673 | A_23_P70161 |
3685 | 1.049 | 9.937 | 12.07 | 3.78e-06 | 9.628 | ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | ENSG00000138448 | 193210 | 3685 | A_23_P50907 |
4646 | 0.9443 | 8.251 | 10.48 | 1.03e-05 | 7.996 | MYO6 | myosin VI | ENSG00000196586 | 600970, 606346, 607821 | 4646 | A_23_P255952 |
4659 | 0.2717 | 7.637 | 7.922 | 8.61e-05 | 4.831 | PPP1R12A | protein phosphatase 1, regulatory (inhibitor) subunit 12A | ENSG00000058272 | 602021 | 4659 | A_23_P204564 |
5021 | 0.8181 | 8.058 | 7.627 | 0.0001136 | 4.418 | OXTR | oxytocin receptor | ENSG00000180914 | 167055 | 5021 | A_23_P132619 |
5052 | 0.8649 | 12.85 | 8.725 | 4.2e-05 | 5.902 | PRDX1 | peroxiredoxin 1 | ENSG00000117450 | 176763 | 5052 | A_23_P11995 |
51422 | -0.5915 | 8.805 | -10.85 | 7.65e-06 | 8.397 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | ENSG00000106617 | 194200, 261740, 600858, 602743 | 51422 | A_23_P44366 |
51762 | 0.3162 | 8.073 | 7.245 | 0.0001691 | 3.866 | RAB8B | RAB8B, member RAS oncogene family | ENSG00000166128 | NA | 51762 | A_23_P37535 |
5270 | 0.661 | 7.854 | 8.993 | 3.29e-05 | 6.242 | SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | ENSG00000135919 | 177010 | 5270 | A_23_P50919 |
5328 | 0.9386 | 13.72 | 13.22 | 2.14e-06 | 10.69 | PLAU | plasminogen activator, urokinase | ENSG00000122861 | 104300, 191840 | 5328 | A_23_P24104 |
5337 | 0.4715 | 7.463 | 6.761 | 0.0002814 | 3.138 | PLD1 | phospholipase D1, phosphatidylcholine-specific | ENSG00000075651 | 602382 | 5337 | A_23_P155335 |
54521 | 0.5212 | 7.455 | 7.564 | 0.0001206 | 4.329 | WDR44 | WD repeat domain 44 | ENSG00000131725 | NA | 54521 | A_23_P171359 |
5569 | 0.6944 | 8.457 | 6.933 | 0.0002309 | 3.4 | PKIA | protein kinase (cAMP-dependent, catalytic) inhibitor alpha | ENSG00000171033 | 606059 | 5569 | A_23_P31765 |
5796 | 0.5916 | 7.852 | 13.22 | 2.14e-06 | 10.7 | PTPRK | protein tyrosine phosphatase, receptor type, K | ENSG00000152894 | 602545 | 5796 | A_23_P254242 |
6447 | 2.663 | 9.132 | 18.1 | 3.02e-07 | 14.31 | SCG5 | secretogranin V (7B2 protein) | ENSG00000166922 | 173120 | 6447 | A_23_P73480 |
6672 | 0.6271 | 7.923 | 10.51 | 1.01e-05 | 8.027 | SP100 | SP100 nuclear antigen | ENSG00000067066 | 604585 | 6672 | A_23_P209712 |
7168 | 0.9907 | 10.52 | 7.894 | 8.8e-05 | 4.793 | TPM1 | tropomyosin 1 (alpha) | ENSG00000140416 | 115196, 191010, 611878 | 7168 | A_23_P363348 |
7205 | -0.84 | 9.181 | -8.028 | 7.73e-05 | 4.978 | TRIP6 | thyroid hormone receptor interactor 6 | ENSG00000087077 | 602933 | 7205 | A_23_P252128 |
7424 | 0.8705 | 9.821 | 11.23 | 6.07e-06 | 8.796 | VEGFC | vascular endothelial growth factor C | ENSG00000150630 | 601528 | 7424 | A_23_P167096 |
7529 | 0.414 | 13.01 | 7.588 | 0.0001177 | 4.363 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | ENSG00000166913 | 601289 | 7529 | A_23_P500251 |
79866 | -0.5261 | 8.071 | -8.691 | 4.3e-05 | 5.859 | C13orf34 | chromosome 13 open reading frame 34 | ENSG00000136122 | 610510 | 79866 | A_23_P25626 |
8086 | 0.5907 | 7.965 | 7.693 | 0.0001061 | 4.512 | AAAS | achalasia, adrenocortical insufficiency, alacrimia | ENSG00000094914 | 231550, 605378 | 8086 | A_23_P64799 |